KMO and epilepsy: Firstly, the study relied solely on a single animal model, specifically, a mouse model of pilocarpine hydrochloride-induced epilepsy, to demonstrate that inhibiting changes in the kynurenine metabolic pathway following KMO activation is associated with the amelioration of seizures, depressive-like behaviors, and cognitive impairment.